Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
OrthoPediatrics price target raised to $72 from $64 at Truist » 09:11
05/07/21
05/07
09:11
05/07/21
09:11
KIDS

OrthoPediatrics

$61.59 /

+5.4 (+9.61%)

Truist analyst Kaila Krum…

Truist analyst Kaila Krum raised the firm's price target on OrthoPediatrics to $72 from $64 and keeps a Buy rating on the shares. The company reported better than expected Q1 results and is staring to see an "inflection point" as it evolves into a "true leader" in pediatric orthopedics, the analyst tells investors in a research note. OrthoPediatrics's Orthex is a strong core business with an emerging pipeline, and she sees "tangible catalysts" that could drive upside to the company's 2022 numbers, Krum adds.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$61.59 /

+5.4 (+9.61%)

KIDS OrthoPediatrics
$61.59 /

+5.4 (+9.61%)

05/07/21 JMP Securities
OrthoPediatrics price target raised to $70 from $55 at JMP Securities
05/06/21 Piper Sandler
OrthoPediatrics price target raised to $70 from $62 at Piper Sandler
04/19/21 Truist
OrthoPediatrics price target raised to $64 from $54 at Truist
04/06/21 Piper Sandler
OrthoPediatrics price target raised to $62 from $55 at Piper Sandler
KIDS OrthoPediatrics
$61.59 /

+5.4 (+9.61%)

  • 18
    Jun
KIDS OrthoPediatrics
$61.59 /

+5.4 (+9.61%)

Recommendations
OrthoPediatrics price target raised to $70 from $55 at JMP Securities » 06:17
05/07/21
05/07
06:17
05/07/21
06:17
KIDS

OrthoPediatrics

/

+

JMP Securities analyst…

JMP Securities analyst David Turkaly raised the firm's price target on OrthoPediatrics to $70 from $55 and keeps an Outperform rating on the shares after its Q1 earnings beat. The company kicked off 2021 with 35% sales growth as strength was "very broad" in each of the company's product divisions, the analyst tells investors in a research note. Turkaly maintains his view of OrthoPediatrics as a "differentiated participant in the largely underserviced pediatric-orthopedic industry" that also offers an opportunity for further penetration in its base markets and entry into complementary orthopedic arenas.

ShowHide Related Items >><<
KIDS OrthoPediatrics
/

+

KIDS OrthoPediatrics
/

+

05/06/21 Piper Sandler
OrthoPediatrics price target raised to $70 from $62 at Piper Sandler
04/19/21 Truist
OrthoPediatrics price target raised to $64 from $54 at Truist
04/06/21 Piper Sandler
OrthoPediatrics price target raised to $62 from $55 at Piper Sandler
12/03/20 Stifel
Stifel says short report claims about OrthoPediatrics 'overstated,' 'inaccurate'
KIDS OrthoPediatrics
/

+

  • 18
    Jun
KIDS OrthoPediatrics
/

+

Thursday
Recommendations
OrthoPediatrics price target raised to $70 from $62 at Piper Sandler » 12:55
05/06/21
05/06
12:55
05/06/21
12:55
KIDS

OrthoPediatrics

$61.65 /

+5.46 (+9.72%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien raised the firm's price target on OrthoPediatrics to $70 from $62 and reiterates an Overweight rating on the shares. The company's key spine franchise delivered "excellent growth" during Q1 and the momentum across the franchise builds with clinician interest in the broad portfolio accelerating, O'Brien tells investors in a research note. The analyst sees the "typical" conservativism in OrthoPediatrics' outlook.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$61.65 /

+5.46 (+9.72%)

KIDS OrthoPediatrics
$61.65 /

+5.46 (+9.72%)

04/19/21 Truist
OrthoPediatrics price target raised to $64 from $54 at Truist
04/06/21 Piper Sandler
OrthoPediatrics price target raised to $62 from $55 at Piper Sandler
12/03/20 Stifel
Stifel says short report claims about OrthoPediatrics 'overstated,' 'inaccurate'
10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
KIDS OrthoPediatrics
$61.65 /

+5.46 (+9.72%)

  • 18
    Jun
KIDS OrthoPediatrics
$61.65 /

+5.46 (+9.72%)

Over a week ago
Recommendations
OrthoPediatrics price target raised to $64 from $54 at Truist » 08:59
04/19/21
04/19
08:59
04/19/21
08:59
KIDS

OrthoPediatrics

$51.33 /

-0.39 (-0.75%)

Truist analyst Kaila Krum…

Truist analyst Kaila Krum raised the firm's price target on OrthoPediatrics to $64 from $54 and keeps a Buy rating on the shares. The analyst states that her call last week with Dr. Ryan Fitzgerald of Riley Children's Hospital - a pediatric orthopedic surgeon with experience using the company's ApiFix - suggests that the market is underestimating how quickly ApiFix will ramp. Krum adds that she now expects the system to generate over $30M for OrthoPediatrics on an annual basis over the next 2-3 years.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$51.33 /

-0.39 (-0.75%)

KIDS OrthoPediatrics
$51.33 /

-0.39 (-0.75%)

04/06/21 Piper Sandler
OrthoPediatrics price target raised to $62 from $55 at Piper Sandler
12/03/20 Stifel
Stifel says short report claims about OrthoPediatrics 'overstated,' 'inaccurate'
10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
KIDS OrthoPediatrics
$51.33 /

-0.39 (-0.75%)

  • 18
    Jun
KIDS OrthoPediatrics
$51.33 /

-0.39 (-0.75%)

Over a month ago
Recommendations
OrthoPediatrics price target raised to $62 from $55 at Piper Sandler » 04:54
04/06/21
04/06
04:54
04/06/21
04:54
KIDS

OrthoPediatrics

$48.72 /

-1.74 (-3.45%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien raised the firm's price target on OrthoPediatrics to $62 from $55 and keeps an Overweight rating on the shares. The analyst says OrthoPediatrics will have the broadest offering of scoliosis products focused on the pediatric market and will capture "significant share," pushing the stock "significantly higher." This is an opportunity not fully appreciated by the Street, O'Brien tells investors in a research note. With its acquisition of ApiFix early last year, OrthoPediatrics can provide a minimally-invasive alternative to bracing and fusion via its MidC system for adolescent idiopathic scoliosis, says the analyst.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$48.72 /

-1.74 (-3.45%)

KIDS OrthoPediatrics
$48.72 /

-1.74 (-3.45%)

12/03/20 Stifel
Stifel says short report claims about OrthoPediatrics 'overstated,' 'inaccurate'
10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
08/06/20 Needham
OrthoPediatrics price target raised to $57 from $49 at Needham
KIDS OrthoPediatrics
$48.72 /

-1.74 (-3.45%)

  • 18
    Jun
KIDS OrthoPediatrics
$48.72 /

-1.74 (-3.45%)

Hot Stocks
OrthoPediatrics announces milestone of 500 scoliosis correction cases worldwide » 08:41
03/23/21
03/23
08:41
03/23/21
08:41
KIDS

OrthoPediatrics

$51.11 /

+0.17 (+0.33%)

OrthoPediatrics announced…

OrthoPediatrics announced that it has surpassed two significant procedure milestones for its ApiFix technology - an exciting alternative for the treatment of progressive adolescent idiopathic scoliosis. Over 500 ApiFix procedures have now been performed treating young AIS patients at centers in the USA, Canada, Europe, Israel, and Asia with long-term clinical follow-up now exceeding nine years. "These are significant milestones for this revolutionary technology and the patients it has benefited all over the world," said David Bailey, President of OrthoPediatrics. "OrthoPediatrics remains committed to providing innovative and game-changing solutions to pediatric caregivers, therapists and surgeons that better enable them to treat their patients. The ApiFix procedure offers select AIS patients a less invasive, motion-preserving option for achieving curve correction - without the permanence of fusion. The ApiFix system's novel approach to correcting spinal deformity is a welcome medical advancement that has the ability to disrupt the continuum of care for scoliosis treatment in certain pediatric patients. Its elegant design and biomechanical considerations combined with the simplistic posterior approach is unmatched. "Our continued review of the extensive clinical experience with the ApiFix system and our ongoing collection of new data continue to underscore ApiFix's positive and encouraging results realized in patients with progressive spinal deformity," commented Daphna Zaroor Regev, PhD, Director of Clinical Affairs at ApiFix Ltd. "We are committed to establishing a new standard of care for spinal deformity treatment and generating peer-reviewed clinical evidence to support its use." The Company has recruited 20 leading clinical centers in the United States to enter data related to the use of the ApiFix system into a post-approval study registry hosted by the Pediatric Spine Study Group. The registry will continue to monitor the safety and probable benefit of the procedure for the treatment of progressive AIS. A typical ApiFix surgical procedure is completed in less than two hours with minimal blood loss and requires a hospital stay of only one or two days. Patient recovery is relatively pain-free and is measured in days, not months, with children able to return to school in just several weeks. The ApiFix MID-C System has FDA and CE Mark approvals.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$51.11 /

+0.17 (+0.33%)

KIDS OrthoPediatrics
$51.11 /

+0.17 (+0.33%)

12/03/20 Stifel
Stifel says short report claims about OrthoPediatrics 'overstated,' 'inaccurate'
10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
08/06/20 Needham
OrthoPediatrics price target raised to $57 from $49 at Needham
KIDS OrthoPediatrics
$51.11 /

+0.17 (+0.33%)

  • 18
    Jun
KIDS OrthoPediatrics
$51.11 /

+0.17 (+0.33%)

Conference/Events
OrthoPediatrics management to meet virtually with Piper Sandler » 04:55
03/05/21
03/05
04:55
03/05/21
04:55
KIDS

OrthoPediatrics

$49.01 /

-2.1 (-4.11%)

Virtual Meeting to be…

Virtual Meeting to be held on March 5 hosted by Piper Sandler.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$49.01 /

-2.1 (-4.11%)

KIDS OrthoPediatrics
$49.01 /

-2.1 (-4.11%)

12/03/20 Stifel
Stifel says short report claims about OrthoPediatrics 'overstated,' 'inaccurate'
10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
08/06/20 Needham
OrthoPediatrics price target raised to $57 from $49 at Needham
KIDS OrthoPediatrics
$49.01 /

-2.1 (-4.11%)

  • 18
    Jun
KIDS OrthoPediatrics
$49.01 /

-2.1 (-4.11%)

Conference/Events
OrthoPediatrics management to meet virtually with Piper Sandler » 12:29
03/04/21
03/04
12:29
03/04/21
12:29
KIDS

OrthoPediatrics

$50.48 /

-0.63 (-1.23%)

Virtual Meeting to be…

Virtual Meeting to be held on March 5 hosted by Piper Sandler.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$50.48 /

-0.63 (-1.23%)

KIDS OrthoPediatrics
$50.48 /

-0.63 (-1.23%)

12/03/20 Stifel
Stifel says short report claims about OrthoPediatrics 'overstated,' 'inaccurate'
10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
08/06/20 Needham
OrthoPediatrics price target raised to $57 from $49 at Needham
KIDS OrthoPediatrics
$50.48 /

-0.63 (-1.23%)

  • 18
    Jun
KIDS OrthoPediatrics
$50.48 /

-0.63 (-1.23%)

Conference/Events
BTIG to hold a virtual conference » 04:55
02/19/21
02/19
04:55
02/19/21
04:55
ABMD

Abiomed

$321.32 /

+4.9 (+1.55%)

, BNGO

Bionano Genomics

$12.82 /

-1.67 (-11.53%)

, CDNA

CareDx

$82.65 /

-2.61 (-3.06%)

, MDVL

Medavail

$15.60 /

-0.54 (-3.35%)

, OFIX

Orthofix

$42.10 /

-0.04 (-0.09%)

, VAPO

Vapotherm

$28.65 /

-1.24 (-4.15%)

, TELA

Tela Bio

$15.00 /

-0.1 (-0.66%)

, TCMD

Tactile Systems

$60.78 /

-0.48 (-0.78%)

, TTOO

T2 Biosystems

$2.92 /

-0.245 (-7.74%)

, STXS

Stereotaxis

$5.50 /

-0.355 (-6.07%)

, PROG

Progenity

$5.32 /

-0.36 (-6.34%)

, QTNT

Quotient

$5.20 /

-0.17 (-3.17%)

, SLP

Simulations Plus

$76.25 /

-3.14 (-3.96%)

, MYGN

Myriad Genetics

$29.71 /

-0.32 (-1.07%)

, NARI

Inari Medical

$114.89 /

-0.98 (-0.85%)

, XENT

Intersect ENT

$23.60 /

-0.86 (-3.52%)

, HOLX

Hologic

$82.31 /

-0.21 (-0.25%)

, ICAD

iCAD

$17.49 /

-0.09 (-0.51%)

, HSKA

Heska

$187.56 /

-13.67 (-6.79%)

, HQY

HealthEquity

$77.95 /

-2.43 (-3.02%)

, FLDM

Fluidigm

$6.42 /

+0.115 (+1.83%)

, MDWD

MediWound

$5.56 /

-0.26 (-4.47%)

, KIDS

OrthoPediatrics

$54.18 /

+2.22 (+4.27%)

, PSNL

Personalis

$38.67 /

-1.11 (-2.79%)

MedTech, Digital Health,…

MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference will be held on February 17-19. Webcast Link

ShowHide Related Items >><<
XENT Intersect ENT
$23.60 /

-0.86 (-3.52%)

VAPO Vapotherm
$28.65 /

-1.24 (-4.15%)

TTOO T2 Biosystems
$2.92 /

-0.245 (-7.74%)

TELA Tela Bio
$15.00 /

-0.1 (-0.66%)

STXS Stereotaxis
$5.50 /

-0.355 (-6.07%)

SLP Simulations Plus
$76.25 /

-3.14 (-3.96%)

QTNT Quotient
$5.20 /

-0.17 (-3.17%)

PSNL Personalis
$38.67 /

-1.11 (-2.79%)

PROG Progenity
$5.32 /

-0.36 (-6.34%)

OFIX Orthofix
$42.10 /

-0.04 (-0.09%)

NARI Inari Medical
$114.89 /

-0.98 (-0.85%)

MYGN Myriad Genetics
$29.71 /

-0.32 (-1.07%)

MDWD MediWound
$5.56 /

-0.26 (-4.47%)

KIDS OrthoPediatrics
$54.18 /

+2.22 (+4.27%)

ICAD iCAD
$17.49 /

-0.09 (-0.51%)

HSKA Heska
$187.56 /

-13.67 (-6.79%)

HQY HealthEquity
$77.95 /

-2.43 (-3.02%)

HOLX Hologic
$82.31 /

-0.21 (-0.25%)

FLDM Fluidigm
$6.42 /

+0.115 (+1.83%)

CDNA CareDx
$82.65 /

-2.61 (-3.06%)

BNGO Bionano Genomics
$12.82 /

-1.67 (-11.53%)

ABMD Abiomed
$321.32 /

+4.9 (+1.55%)

ABMD Abiomed
$321.32 /

+4.9 (+1.55%)

01/28/21 Piper Sandler
Abiomed price target raised to $425 from $350 at Piper Sandler
12/21/20 SVB Leerink
Abiomed price target raised to $320 from $280 at SVB Leerink
12/14/20 Piper Sandler
Abiomed gets approval for XR sheath, says Piper Sandler
10/20/20 Piper Sandler
Abiomed's TCT presentation highlights solid existing data, says Piper Sandler
BNGO Bionano Genomics
$12.82 /

-1.67 (-11.53%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
CDNA CareDx
$82.65 /

-2.61 (-3.06%)

01/12/21 Piper Sandler
CareDx price target raised to $93 from $62 at Piper Sandler
01/04/21 Craig-Hallum
CareDx price target raised to $94 from $66 at Craig-Hallum
12/17/20 BTIG
CareDx price target raised to $80 from $55 at BTIG
12/10/20 Raymond James
CareDx price target raised to $75 from $62 at Raymond James
MDVL Medavail
$15.60 /

-0.54 (-3.35%)

12/14/20 Lake Street
Medavail initiated with a Buy at Lake Street
12/14/20 Cowen
Medavail initiated with an Outperform at Cowen
OFIX Orthofix
$42.10 /

-0.04 (-0.09%)

10/19/20 Stifel
Orthofix initiated with a Hold at Stifel
02/25/20 Cantor Fitzgerald
Orthofix price target lowered to $42 from $48 at Cantor Fitzgerald
VAPO Vapotherm
$28.65 /

-1.24 (-4.15%)

01/15/21 Piper Sandler
Vapotherm price target raised to $39 from $36 at Piper Sandler
01/13/21 Piper Sandler
Vapotherm remains top small pick at Piper Sandler
12/17/20
Fly Intel: Top five analyst initiations
12/17/20 Piper Sandler
Vapotherm initiated with an Overweight at Piper Sandler
TELA Tela Bio
$15.00 /

-0.1 (-0.66%)

01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
11/11/20 Piper Sandler
Tela Bio price target raised to $20 from $17 at Piper Sandler
08/12/20 Piper Sandler
Tela Bio price target raised to $17 from $14 at Piper Sandler
07/09/20 Piper Sandler
Piper recommends buying Tela Bio shares after 'strong' OviTex data
TCMD Tactile Systems
$60.78 /

-0.48 (-0.78%)

01/25/21 BTIG
Tactile Systems price target raised to $60 from $51 at BTIG
11/13/20 Oppenheimer
Tactile Systems upgraded to Outperform from Perform at Oppenheimer
11/13/20 Oppenheimer
Tactile Systems upgraded to Outperform from Perform at Oppenheimer
11/03/20 Piper Sandler
Tactile Systems shares still recommended after results at Piper Sandler
TTOO T2 Biosystems
$2.92 /

-0.245 (-7.74%)

01/27/21 Alliance Global Partners
T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners
11/05/20 Alliance Global Partners
T2 Biosystems price target raised to $2.60 from $1.65 at Alliance Global
10/07/20 BTIG
T2 Biosystems initiated with a Buy at BTIG
09/30/20 JonesTrading
JonesTrading reiterates $3.50 target on T2 Biosystems after BARDA contract
STXS Stereotaxis
$5.50 /

-0.355 (-6.07%)

09/08/20 Northland
Stereotaxis initiated with an Outperform at Northland
06/22/20 Lake Street
Stereotaxis price target raised to $9 from $5 at Lake Street
05/27/20 Lake Street
Stereotaxis financing, addition of Consonance both positive, says Lake Street
04/09/20 Cowen
Stereotaxis initiated with an Outperform at Cowen
PROG Progenity
$5.32 /

-0.36 (-6.34%)

02/08/21 Wells Fargo
Progenity downgraded to Underweight from Overweight at Wells Fargo
01/14/21 Piper Sandler
Progenity price target lowered to $10 from $15 at Piper Sandler
12/08/20 Piper Sandler
Progenity shares not trading on fundamentals, says Piper Sandler
11/10/20 Piper Sandler
Progenity price target lowered to $15 from $17 at Piper Sandler
QTNT Quotient
$5.20 /

-0.17 (-3.17%)

05/18/20 Cowen
Quotient partner update suggests progress on antibody front, says Cowen
SLP Simulations Plus
$76.25 /

-3.14 (-3.96%)

01/12/21
Fly Intel: Top five analyst downgrades
01/12/21 Craig-Hallum
Simulations Plus downgraded to Hold from Buy at Craig-Hallum
01/12/21 Oppenheimer
Simulations Plus price target raised to $85 from $79 at Oppenheimer
11/25/20 Taglich Brothers
Simulations Plus upgraded to Buy from Speculative Buy at Taglich Brothers
MYGN Myriad Genetics
$29.71 /

-0.32 (-1.07%)

11/10/20 Piper Sandler
Myriad Genetics price target raised to $18 from $14 at Piper Sandler
08/17/20 Piper Sandler
ACOG recommendation 'extremely' positive for Natera and Progenity, says Piper
06/11/20 Piper Sandler
Palmetto coverage language unclear about Myriad's GeneSight, says Piper Sandler
05/06/20 JPMorgan
Myriad Genetics price target lowered to $12 from $14 at JPMorgan
NARI Inari Medical
$114.89 /

-0.98 (-0.85%)

01/21/21 BTIG
Inari Medical price target raised to $110 from $92 at BTIG
01/20/21 Wells Fargo
Inari Medical price target raised to $112 from $79 at Wells Fargo
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Inari Medical upgraded to Overweight from Equal Weight at Wells Fargo
XENT Intersect ENT
$23.60 /

-0.86 (-3.52%)

01/15/21 Piper Sandler
Intersect ENT price target raised to $23 from $17 at Piper Sandler
01/11/21 Canaccord
Intersect ENT upgraded to Buy from Hold at Canaccord
11/19/20 BTIG
Intersect ENT upgraded to Buy from Neutral at BTIG
11/02/20 Piper Sandler
Intersect ENT price target raised to $17 from $16 at Piper Sandler
HOLX Hologic
$82.31 /

-0.21 (-0.25%)

01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
11/20/20 Needham
Needham downgrades Hologic ahead of COVID-19 testing decline
ICAD iCAD
$17.49 /

-0.09 (-0.51%)

01/28/21 Cantor Fitzgerald
Cantor Fitzgerald starts iCAD at Overweight with $19 price target
01/28/21 Cantor Fitzgerald
iCAD initiated with an Overweight at Cantor Fitzgerald
12/15/20 B. Riley
iCAD price target raised to $18 from $15 at B. Riley Securities
12/11/20 Lake Street
iCAD price target raised to $17 from $14 at Lake Street
HSKA Heska
$187.56 /

-13.67 (-6.79%)

01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
11/04/20 Alliance Global Partners
Heska price target raised to $163.50 from $116.50 at Alliance Global Partners
10/21/20 Raymond James
Heska upgraded to Outperform from Market Perform at Raymond James
HQY HealthEquity
$77.95 /

-2.43 (-3.02%)

02/10/21 Raymond James
HealthEquity price target raised to $100 from $75 at Raymond James
02/09/21 Barrington
HealthEquity price target raised to $90 from $75 at Barrington
02/09/21 Truist
HealthEquity price target raised to $92 from $80 at Truist
02/09/21 RBC Capital
HealthEquity price target raised to $87 from $74 at RBC Capital
FLDM Fluidigm
$6.42 /

+0.115 (+1.83%)

02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
10/19/20 Piper Sandler
Fluidigm test pact in Texas 'another validation,' says Piper Sandler
MDWD MediWound
$5.56 /

-0.26 (-4.47%)

10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
09/23/20
Fly Intel: Top five analyst initiations
09/23/20 BTIG
MediWound initiated with a Buy at BTIG
KIDS OrthoPediatrics
$54.18 /

+2.22 (+4.27%)

12/03/20 Stifel
Stifel says short report claims about OrthoPediatrics 'overstated,' 'inaccurate'
10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
08/06/20 Needham
OrthoPediatrics price target raised to $57 from $49 at Needham
PSNL Personalis
$38.67 /

-1.11 (-2.79%)

01/27/21 Truist
Personalis initiated with a Buy at Truist
01/04/21 BofA
Personalis downgraded to Neutral on valuation at BofA
01/04/21 BofA
Personalis downgraded to Neutral from Buy at BofA
12/17/20 BTIG
BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks'
XENT Intersect ENT
$23.60 /

-0.86 (-3.52%)

VAPO Vapotherm
$28.65 /

-1.24 (-4.15%)

TTOO T2 Biosystems
$2.92 /

-0.245 (-7.74%)

TELA Tela Bio
$15.00 /

-0.1 (-0.66%)

STXS Stereotaxis
$5.50 /

-0.355 (-6.07%)

SLP Simulations Plus
$76.25 /

-3.14 (-3.96%)

QTNT Quotient
$5.20 /

-0.17 (-3.17%)

PSNL Personalis
$38.67 /

-1.11 (-2.79%)

PROG Progenity
$5.32 /

-0.36 (-6.34%)

OFIX Orthofix
$42.10 /

-0.04 (-0.09%)

NARI Inari Medical
$114.89 /

-0.98 (-0.85%)

MYGN Myriad Genetics
$29.71 /

-0.32 (-1.07%)

MDWD MediWound
$5.56 /

-0.26 (-4.47%)

KIDS OrthoPediatrics
$54.18 /

+2.22 (+4.27%)

ICAD iCAD
$17.49 /

-0.09 (-0.51%)

HQY HealthEquity
$77.95 /

-2.43 (-3.02%)

HOLX Hologic
$82.31 /

-0.21 (-0.25%)

FLDM Fluidigm
$6.42 /

+0.115 (+1.83%)

CDNA CareDx
$82.65 /

-2.61 (-3.06%)

BNGO Bionano Genomics
$12.82 /

-1.67 (-11.53%)

ABMD Abiomed
$321.32 /

+4.9 (+1.55%)

  • 17
    Feb
  • 27
    Jan
  • 21
    Jan
  • 20
    Jan
  • 08
    Jan
  • 03
    Dec
  • 11
    Sep
  • 12
    Aug
  • 06
    Aug
  • 09
    Jul
  • 26
    Jun
  • 18
    Jun
  • 19
    Jun
  • 11
    Jun
  • 22
    May
  • 07
    May
KIDS OrthoPediatrics
$54.18 /

+2.22 (+4.27%)

HOLX Hologic
$82.31 /

-0.21 (-0.25%)

FLDM Fluidigm
$6.42 /

+0.115 (+1.83%)

VAPO Vapotherm
$28.65 /

-1.24 (-4.15%)

TTOO T2 Biosystems
$2.92 /

-0.245 (-7.74%)

QTNT Quotient
$5.20 /

-0.17 (-3.17%)

PSNL Personalis
$38.67 /

-1.11 (-2.79%)

PROG Progenity
$5.32 /

-0.36 (-6.34%)

MDWD MediWound
$5.56 /

-0.26 (-4.47%)

MDVL Medavail
$15.60 /

-0.54 (-3.35%)

HQY HealthEquity
$77.95 /

-2.43 (-3.02%)

HOLX Hologic
$82.31 /

-0.21 (-0.25%)

FLDM Fluidigm
$6.42 /

+0.115 (+1.83%)

CDNA CareDx
$82.65 /

-2.61 (-3.06%)

BNGO Bionano Genomics
$12.82 /

-1.67 (-11.53%)

VAPO Vapotherm
$28.65 /

-1.24 (-4.15%)

TTOO T2 Biosystems
$2.92 /

-0.245 (-7.74%)

SLP Simulations Plus
$76.25 /

-3.14 (-3.96%)

PROG Progenity
$5.32 /

-0.36 (-6.34%)

MYGN Myriad Genetics
$29.71 /

-0.32 (-1.07%)

HQY HealthEquity
$77.95 /

-2.43 (-3.02%)

HOLX Hologic
$82.31 /

-0.21 (-0.25%)

FLDM Fluidigm
$6.42 /

+0.115 (+1.83%)

BNGO Bionano Genomics
$12.82 /

-1.67 (-11.53%)

Conference/Events
BTIG to hold a virtual conference » 09:30
02/18/21
02/18
09:30
02/18/21
09:30
ABMD

Abiomed

$316.00 /

-7.27 (-2.25%)

, BNGO

Bionano Genomics

$14.49 /

-1.11 (-7.12%)

, CDNA

CareDx

$85.26 /

-2.66 (-3.03%)

, MDVL

Medavail

$16.14 /

+1.97 (+13.90%)

, OFIX

Orthofix

$42.49 /

-0.68 (-1.58%)

, VAPO

Vapotherm

$29.89 /

-0.86 (-2.80%)

, TELA

Tela Bio

$15.20 /

+0.2 (+1.33%)

, TCMD

Tactile Systems

$61.48 /

-0.11 (-0.18%)

, TTOO

T2 Biosystems

$3.17 /

-0.175 (-5.23%)

, STXS

Stereotaxis

$5.85 /

+0.255 (+4.56%)

, PROG

Progenity

$5.68 /

+0.02 (+0.35%)

, QTNT

Quotient

$5.37 /

-0.02 (-0.37%)

, SLP

Simulations Plus

$79.31 /

-5.32 (-6.29%)

, MYGN

Myriad Genetics

$30.03 /

-0.01 (-0.03%)

, NARI

Inari Medical

$115.80 /

-0.98 (-0.84%)

, XENT

Intersect ENT

$24.56 /

-0.09 (-0.37%)

, HOLX

Hologic

$82.52 /

-0.85 (-1.02%)

, ICAD

iCAD

$17.53 /

-0.4 (-2.23%)

, HSKA

Heska

$198.88 /

+0.26 (+0.13%)

, HQY

HealthEquity

$80.40 /

-5.15 (-6.02%)

, FLDM

Fluidigm

$6.30 /

+0.91 (+16.88%)

, MDWD

MediWound

$5.81 /

+0.01 (+0.17%)

, KIDS

OrthoPediatrics

$51.91 /

-0.075 (-0.14%)

, PSNL

Personalis

$39.78 /

-0.37 (-0.92%)

MedTech, Digital Health,…

MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference will be held on February 17-19. Webcast Link

ShowHide Related Items >><<
XENT Intersect ENT
$24.56 /

-0.09 (-0.37%)

VAPO Vapotherm
$29.89 /

-0.86 (-2.80%)

TTOO T2 Biosystems
$3.17 /

-0.175 (-5.23%)

TELA Tela Bio
$15.20 /

+0.2 (+1.33%)

STXS Stereotaxis
$5.85 /

+0.255 (+4.56%)

SLP Simulations Plus
$79.31 /

-5.32 (-6.29%)

QTNT Quotient
$5.37 /

-0.02 (-0.37%)

PSNL Personalis
$39.78 /

-0.37 (-0.92%)

PROG Progenity
$5.68 /

+0.02 (+0.35%)

OFIX Orthofix
$42.49 /

-0.68 (-1.58%)

NARI Inari Medical
$115.80 /

-0.98 (-0.84%)

MYGN Myriad Genetics
$30.03 /

-0.01 (-0.03%)

MDWD MediWound
$5.81 /

+0.01 (+0.17%)

KIDS OrthoPediatrics
$51.91 /

-0.075 (-0.14%)

ICAD iCAD
$17.53 /

-0.4 (-2.23%)

HSKA Heska
$198.88 /

+0.26 (+0.13%)

HQY HealthEquity
$80.40 /

-5.15 (-6.02%)

HOLX Hologic
$82.52 /

-0.85 (-1.02%)

FLDM Fluidigm
$6.30 /

+0.91 (+16.88%)

CDNA CareDx
$85.26 /

-2.66 (-3.03%)

BNGO Bionano Genomics
$14.49 /

-1.11 (-7.12%)

ABMD Abiomed
$316.00 /

-7.27 (-2.25%)

ABMD Abiomed
$316.00 /

-7.27 (-2.25%)

01/28/21 Piper Sandler
Abiomed price target raised to $425 from $350 at Piper Sandler
12/21/20 SVB Leerink
Abiomed price target raised to $320 from $280 at SVB Leerink
12/14/20 Piper Sandler
Abiomed gets approval for XR sheath, says Piper Sandler
10/20/20 Piper Sandler
Abiomed's TCT presentation highlights solid existing data, says Piper Sandler
BNGO Bionano Genomics
$14.49 /

-1.11 (-7.12%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
CDNA CareDx
$85.26 /

-2.66 (-3.03%)

01/12/21 Piper Sandler
CareDx price target raised to $93 from $62 at Piper Sandler
01/04/21 Craig-Hallum
CareDx price target raised to $94 from $66 at Craig-Hallum
12/17/20 BTIG
CareDx price target raised to $80 from $55 at BTIG
12/10/20 Raymond James
CareDx price target raised to $75 from $62 at Raymond James
MDVL Medavail
$16.14 /

+1.97 (+13.90%)

12/14/20 Lake Street
Medavail initiated with a Buy at Lake Street
12/14/20 Cowen
Medavail initiated with an Outperform at Cowen
OFIX Orthofix
$42.49 /

-0.68 (-1.58%)

10/19/20 Stifel
Orthofix initiated with a Hold at Stifel
02/25/20 Cantor Fitzgerald
Orthofix price target lowered to $42 from $48 at Cantor Fitzgerald
VAPO Vapotherm
$29.89 /

-0.86 (-2.80%)

01/15/21 Piper Sandler
Vapotherm price target raised to $39 from $36 at Piper Sandler
01/13/21 Piper Sandler
Vapotherm remains top small pick at Piper Sandler
12/17/20
Fly Intel: Top five analyst initiations
12/17/20 Piper Sandler
Vapotherm initiated with an Overweight at Piper Sandler
TELA Tela Bio
$15.20 /

+0.2 (+1.33%)

01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
11/11/20 Piper Sandler
Tela Bio price target raised to $20 from $17 at Piper Sandler
08/12/20 Piper Sandler
Tela Bio price target raised to $17 from $14 at Piper Sandler
07/09/20 Piper Sandler
Piper recommends buying Tela Bio shares after 'strong' OviTex data
TCMD Tactile Systems
$61.48 /

-0.11 (-0.18%)

01/25/21 BTIG
Tactile Systems price target raised to $60 from $51 at BTIG
11/13/20 Oppenheimer
Tactile Systems upgraded to Outperform from Perform at Oppenheimer
11/13/20 Oppenheimer
Tactile Systems upgraded to Outperform from Perform at Oppenheimer
11/03/20 Piper Sandler
Tactile Systems shares still recommended after results at Piper Sandler
TTOO T2 Biosystems
$3.17 /

-0.175 (-5.23%)

01/27/21 Alliance Global Partners
T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners
11/05/20 Alliance Global Partners
T2 Biosystems price target raised to $2.60 from $1.65 at Alliance Global
10/07/20 BTIG
T2 Biosystems initiated with a Buy at BTIG
09/30/20 JonesTrading
JonesTrading reiterates $3.50 target on T2 Biosystems after BARDA contract
STXS Stereotaxis
$5.85 /

+0.255 (+4.56%)

09/08/20 Northland
Stereotaxis initiated with an Outperform at Northland
06/22/20 Lake Street
Stereotaxis price target raised to $9 from $5 at Lake Street
05/27/20 Lake Street
Stereotaxis financing, addition of Consonance both positive, says Lake Street
04/09/20 Cowen
Stereotaxis initiated with an Outperform at Cowen
PROG Progenity
$5.68 /

+0.02 (+0.35%)

02/08/21 Wells Fargo
Progenity downgraded to Underweight from Overweight at Wells Fargo
01/14/21 Piper Sandler
Progenity price target lowered to $10 from $15 at Piper Sandler
12/08/20 Piper Sandler
Progenity shares not trading on fundamentals, says Piper Sandler
11/10/20 Piper Sandler
Progenity price target lowered to $15 from $17 at Piper Sandler
QTNT Quotient
$5.37 /

-0.02 (-0.37%)

05/18/20 Cowen
Quotient partner update suggests progress on antibody front, says Cowen
SLP Simulations Plus
$79.31 /

-5.32 (-6.29%)

01/12/21
Fly Intel: Top five analyst downgrades
01/12/21 Craig-Hallum
Simulations Plus downgraded to Hold from Buy at Craig-Hallum
01/12/21 Oppenheimer
Simulations Plus price target raised to $85 from $79 at Oppenheimer
11/25/20 Taglich Brothers
Simulations Plus upgraded to Buy from Speculative Buy at Taglich Brothers
MYGN Myriad Genetics
$30.03 /

-0.01 (-0.03%)

11/10/20 Piper Sandler
Myriad Genetics price target raised to $18 from $14 at Piper Sandler
08/17/20 Piper Sandler
ACOG recommendation 'extremely' positive for Natera and Progenity, says Piper
06/11/20 Piper Sandler
Palmetto coverage language unclear about Myriad's GeneSight, says Piper Sandler
05/06/20 JPMorgan
Myriad Genetics price target lowered to $12 from $14 at JPMorgan
NARI Inari Medical
$115.80 /

-0.98 (-0.84%)

01/21/21 BTIG
Inari Medical price target raised to $110 from $92 at BTIG
01/20/21 Wells Fargo
Inari Medical price target raised to $112 from $79 at Wells Fargo
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Inari Medical upgraded to Overweight from Equal Weight at Wells Fargo
XENT Intersect ENT
$24.56 /

-0.09 (-0.37%)

01/15/21 Piper Sandler
Intersect ENT price target raised to $23 from $17 at Piper Sandler
01/11/21 Canaccord
Intersect ENT upgraded to Buy from Hold at Canaccord
11/19/20 BTIG
Intersect ENT upgraded to Buy from Neutral at BTIG
11/02/20 Piper Sandler
Intersect ENT price target raised to $17 from $16 at Piper Sandler
HOLX Hologic
$82.52 /

-0.85 (-1.02%)

01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
11/20/20 Needham
Needham downgrades Hologic ahead of COVID-19 testing decline
ICAD iCAD
$17.53 /

-0.4 (-2.23%)

01/28/21 Cantor Fitzgerald
Cantor Fitzgerald starts iCAD at Overweight with $19 price target
01/28/21 Cantor Fitzgerald
iCAD initiated with an Overweight at Cantor Fitzgerald
12/15/20 B. Riley
iCAD price target raised to $18 from $15 at B. Riley Securities
12/11/20 Lake Street
iCAD price target raised to $17 from $14 at Lake Street
HSKA Heska
$198.88 /

+0.26 (+0.13%)

01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
11/04/20 Alliance Global Partners
Heska price target raised to $163.50 from $116.50 at Alliance Global Partners
10/21/20 Raymond James
Heska upgraded to Outperform from Market Perform at Raymond James
HQY HealthEquity
$80.40 /

-5.15 (-6.02%)

02/10/21 Raymond James
HealthEquity price target raised to $100 from $75 at Raymond James
02/09/21 Barrington
HealthEquity price target raised to $90 from $75 at Barrington
02/09/21 Truist
HealthEquity price target raised to $92 from $80 at Truist
02/09/21 RBC Capital
HealthEquity price target raised to $87 from $74 at RBC Capital
FLDM Fluidigm
$6.30 /

+0.91 (+16.88%)

02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
10/19/20 Piper Sandler
Fluidigm test pact in Texas 'another validation,' says Piper Sandler
MDWD MediWound
$5.81 /

+0.01 (+0.17%)

10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
09/23/20
Fly Intel: Top five analyst initiations
09/23/20 BTIG
MediWound initiated with a Buy at BTIG
KIDS OrthoPediatrics
$51.91 /

-0.075 (-0.14%)

12/03/20 Stifel
Stifel says short report claims about OrthoPediatrics 'overstated,' 'inaccurate'
10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
08/06/20 Needham
OrthoPediatrics price target raised to $57 from $49 at Needham
PSNL Personalis
$39.78 /

-0.37 (-0.92%)

01/27/21 Truist
Personalis initiated with a Buy at Truist
01/04/21 BofA
Personalis downgraded to Neutral on valuation at BofA
01/04/21 BofA
Personalis downgraded to Neutral from Buy at BofA
12/17/20 BTIG
BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks'
XENT Intersect ENT
$24.56 /

-0.09 (-0.37%)

VAPO Vapotherm
$29.89 /

-0.86 (-2.80%)

TTOO T2 Biosystems
$3.17 /

-0.175 (-5.23%)

TELA Tela Bio
$15.20 /

+0.2 (+1.33%)

STXS Stereotaxis
$5.85 /

+0.255 (+4.56%)

SLP Simulations Plus
$79.31 /

-5.32 (-6.29%)

QTNT Quotient
$5.37 /

-0.02 (-0.37%)

PSNL Personalis
$39.78 /

-0.37 (-0.92%)

PROG Progenity
$5.68 /

+0.02 (+0.35%)

OFIX Orthofix
$42.49 /

-0.68 (-1.58%)

NARI Inari Medical
$115.80 /

-0.98 (-0.84%)

MYGN Myriad Genetics
$30.03 /

-0.01 (-0.03%)

MDWD MediWound
$5.81 /

+0.01 (+0.17%)

KIDS OrthoPediatrics
$51.91 /

-0.075 (-0.14%)

ICAD iCAD
$17.53 /

-0.4 (-2.23%)

HQY HealthEquity
$80.40 /

-5.15 (-6.02%)

HOLX Hologic
$82.52 /

-0.85 (-1.02%)

FLDM Fluidigm
$6.30 /

+0.91 (+16.88%)

CDNA CareDx
$85.26 /

-2.66 (-3.03%)

BNGO Bionano Genomics
$14.49 /

-1.11 (-7.12%)

ABMD Abiomed
$316.00 /

-7.27 (-2.25%)

  • 17
    Feb
  • 27
    Jan
  • 21
    Jan
  • 20
    Jan
  • 08
    Jan
  • 03
    Dec
  • 11
    Sep
  • 12
    Aug
  • 06
    Aug
  • 09
    Jul
  • 26
    Jun
  • 18
    Jun
  • 19
    Jun
  • 11
    Jun
  • 22
    May
  • 07
    May
KIDS OrthoPediatrics
$51.91 /

-0.075 (-0.14%)

HOLX Hologic
$82.52 /

-0.85 (-1.02%)

FLDM Fluidigm
$6.30 /

+0.91 (+16.88%)

VAPO Vapotherm
$29.89 /

-0.86 (-2.80%)

TTOO T2 Biosystems
$3.17 /

-0.175 (-5.23%)

QTNT Quotient
$5.37 /

-0.02 (-0.37%)

PSNL Personalis
$39.78 /

-0.37 (-0.92%)

PROG Progenity
$5.68 /

+0.02 (+0.35%)

MDWD MediWound
$5.81 /

+0.01 (+0.17%)

MDVL Medavail
$16.14 /

+1.97 (+13.90%)

HQY HealthEquity
$80.40 /

-5.15 (-6.02%)

HOLX Hologic
$82.52 /

-0.85 (-1.02%)

FLDM Fluidigm
$6.30 /

+0.91 (+16.88%)

CDNA CareDx
$85.26 /

-2.66 (-3.03%)

BNGO Bionano Genomics
$14.49 /

-1.11 (-7.12%)

VAPO Vapotherm
$29.89 /

-0.86 (-2.80%)

TTOO T2 Biosystems
$3.17 /

-0.175 (-5.23%)

SLP Simulations Plus
$79.31 /

-5.32 (-6.29%)

PROG Progenity
$5.68 /

+0.02 (+0.35%)

MYGN Myriad Genetics
$30.03 /

-0.01 (-0.03%)

HQY HealthEquity
$80.40 /

-5.15 (-6.02%)

HOLX Hologic
$82.52 /

-0.85 (-1.02%)

FLDM Fluidigm
$6.30 /

+0.91 (+16.88%)

BNGO Bionano Genomics
$14.49 /

-1.11 (-7.12%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.